BPA Call 36C25722A0004-36C25725N0025

Award Date 11/15/24
Potential Completion Date 11/14/25
Potential Value $65K
Ultimate Awardee
Veracyte, Inc.
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78216, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the modification of the Decipher Prostate Cancer Testing service. The $64,811.80 contract has an ultimate completion date of November 14, 2026 and is not set aside. Veracyte, a for-profit medical diagnostics company, provides specialized genomic testing services to support precision medicine and personalized...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract, valued at $194,435.40, is a Blanket Purchase Agreement (BPA) call order issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract vehicle. The contract is for Veracyte Labs to provide its proprietary Decipher Prostate Cancer Test, a genomic classifier that...
This is a firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract, valued at $372,667.85, is for the delivery of the Decipher Prostate Cancer Test, a specialized genomic diagnostic service that analyzes tumor gene expression patterns to help clinicians assess prostate cancer risk and guide treatment decisions. The contract is a Blanket Purchase Agreement...
This is a federal contract award to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., for DECIPHER PROSTATE CANCER TESTING services. The contract, valued at $3,240.59, was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). This is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does...
This federal contract award, valued at $184,713.63, was made by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract is for the provision of the Decipher Prostate Cancer Test, a specialized genomic classifier that analyzes tumor gene expression patterns to help clinicians make more informed treatment decisions for prostate cancer patients. The contract is a Blanket Purchase...
This federal contract award, valued at $61,571.21, was issued by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is for the Decipher Prostate Cancer Testing service, which analyzes tumor gene expression patterns to help clinicians make more informed treatment...
This is a federal contract award to Veracyte Labs SD Corporation, a division of Veracyte, Inc., to provide the Decipher Prostate Cancer Test, a genomic classifier test that analyzes tumor gene expression patterns to help clinicians make more informed treatment decisions for prostate cancer. The contract, valued at $359,705.49, is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) under the Medical Laboratory Testing and Analysis Services Federal Supply...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is for the provision of Veracyte's proprietary Decipher Prostate Cancer Testing, Packaging, and Transport services to the VA San Francisco healthcare facility. The contract has a ceiling value of $648,118.00 and a period of performance through...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call contract to Veracyte Labs SD Corporation, operating through its Decipher Biosciences, Inc. division, for $294,893.69 to provide the Decipher Prostate Cancer Test. This specialized genomic test analyzes tumor gene expression patterns to help clinicians make more informed treatment decisions for prostate cancer patients, supporting the VA's efforts to deliver precision medicine for veterans. The contract...
This federal contract award with ID 36C25722A0004|36C25723N0010 was made by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., a for-profit organization that specializes in advanced molecular diagnostic services for cancer. The $38,887.08 firm fixed-price contract is for the Decipher Prostate Cancer Testing service under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). This contract supports the VA's...

This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the modification and delivery of the Decipher Prostate Cancer Testing service. The contract, valued at $64,811.80, is a Blanket Purchase Agreement (BPA) call placed under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract supports the VA's goal of providing personalized cancer care to veterans by enabling access to Veracyte's specialized genomic testing capabilities through this BPA. The contract has no set-aside designation, reflecting the highly specialized nature of the services provided. Veracyte holds several significant Indefinite Delivery Vehicle (IDV) contracts with the VA and the Defense Health Agency, valued up to $1.95 million, that facilitate the procurement of its advanced molecular diagnostic services for prostate cancer.

Generated 5/16/25, 12:19 PM